Login

Atenetic 50/12.5mg & 100/25mg Film - coated Tablets *

  • Company:

    Gerard Laboratories

  • Status:

    No Recent Update

  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)

  • Active Ingredient(s):

    Atenolol Chlortalidone

    *Additional information is available within the SPC or upon request to the company

  • undefined
  • undefined
  • undefined
  • undefined

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 20 December 2018

File name

ateni ie-pl-clean-maht_1545319757.pdf

Reasons for updating

  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - marketing authorisation number
  • Change to section 6 - date of revision

Updated on 20 December 2018

File name

Ateni ie-spc-100mg25mg-clean-maht_1545319796.pdf

Reasons for updating

  • Change to section 7 - Marketing authorisation holder
  • Change to section 8 - Marketing authorisation number(s)
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 08 February 2016

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may not be renewed (A)

Updated on 29 January 2016

File name

PIL_9018_537.pdf

Reasons for updating

  • New PIL for new product

Updated on 29 January 2016

Reasons for updating

  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
  • Change to dosage and administration
  • Addition of manufacturer

Updated on 30 October 2015

Reasons for updating

  • Change to side-effects

Updated on 29 May 2013

Reasons for updating

  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to instructions about overdose
  • Change to side-effects
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to how the medicine works
  • Change to date of revision
  • Change to dosage and administration
  • Change to improve clarity and readability
  • Change due to harmonisation of PIL

Updated on 16 November 2011

Reasons for updating

  • Change to warnings or special precautions for use
  • Change of contraindications
  • Change to side-effects
  • Change to drug interactions
  • Change due to user-testing of patient information

Updated on 02 October 2006

Reasons for updating

  • Correction of spelling/typing errors

Updated on 23 August 2006

Reasons for updating

  • Change of active ingredient
  • Change to date of revision
  • Change to further information section
  • Change to storage instructions

Updated on 23 September 2004

Reasons for updating

  • New PIL for medicines.ie